Early Cancer Detection in Li–Fraumeni Syndrome with Cell-Free DNA

As you may have heard that Liquid biopsy has become an attractive tool for a range of clinical applications, including early cancer detection. Scientists investigates, “liquid biopsy shows earlier detection of cancer in patients with LFS compared with current clinical surveillance methods such as imaging”, by utilizing an integrated cell-free DNA approach. Liquid biopsy provides improved accessibility and sensitivity, complementing current clinical surveillance methods to provide better care for these patients.



Posted on:

Subscribe to our Newsletter

Full Name



Your form submitted successfully!


Sorry! your form was not submitted properly, Please check the errors above.